(Q30396657)

21 June 2017

title

New adjuvanted vaccines in pregnancy: what is known about their safety? (English)

1 reference

21 June 2017

author

Jan Willem van der Laan

3

object named as

Jan Willem van der Laan

0 references

author name string

Carla Herberts

1

1 reference

21 June 2017

Barbro Melgert

2

1 reference

21 June 2017

Jan Willem van der Laan

3

1 reference

21 June 2017

Marijke Faas

4

1 reference

21 June 2017

publication date

1 December 2010

1 reference

Expert Review of Vaccines

21 June 2017

published in

1 reference

21 June 2017

volume

9

1 reference

21 June 2017

issue

12

1 reference

21 June 2017

page(s)

1411-1422

1 reference

Is routine influenza immunization warranted in early pregnancy?

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Influenza vaccination in pregnancy: current evidence and selected national policies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Effectiveness of maternal influenza immunization in mothers and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Delivering influenza vaccine to pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Vaccines for pertussis and influenza: recommendations for use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The case for maternal vaccination against pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Human uterine leukocytes and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The pathology of gestational trophoblastic disease: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The immunomodulatory roles of macrophages at the maternal-fetal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Uterine leukocytes and decidualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The role of regulatory T cells in alloantigen tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

CD83(+)dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Human decidua contains potent immunostimulatory CD83(+) dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The immunology of successful pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Immunology of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Plasma of pregnant and preeclamptic women activates monocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Normal pregnancy is associated with peripheral leukocyte activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Differences in circulating dendritic cell subtypes in pregnant women, cord blood and healthy adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Immunologically mediated abortions: one or several pathways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Acute herpes hepatitis in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Malaria in pregnancy: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Endotoxin induced intraplacental thrombotic tendency and decreased vascular adpase in the pregnant rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Extracellular ATP induces albuminuria in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The path to a successful vaccine adjuvant--'the long and winding road'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Improving vaccines by incorporating immunological coadjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Towards an understanding of the adjuvant action of aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Immunology of TLR-independent vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Dendritic cells internalize vaccine adjuvant after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Mechanism of action of clinically approved adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

A family of human receptors structurally related to Drosophila Toll

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

21 January 2018

ISCOMs and ISCOMATRIX.

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Adjuvant activity of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Safety of influenza vaccination during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Safety of influenza vaccination during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Early exposure to yellow fever vaccine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Birth defects among infants born to women who received anthrax vaccine in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Placental transport of immunoglobulin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Induction of HIV-1 MPR(649-684)-specific IgA and IgG antibodies in caprine colostrum using a peptide-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Field trial of two dual vaccines against Mycoplasma agalactiae and Mycoplasma mycoides subsp. mycoides (large colony type) in goats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Immunological control of congenital toxoplasmosis in the murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Pregnant women deserve better

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Cytokines and fever. Mechanisms and sites of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.133

21 January 2018

Identifiers

DOI

10.1586/ERV.10.133

1 reference

21 June 2017

1 reference